D. Finkelstein

发表

Breast cancer in China.

Wanqing Chen, L. Fan, K. Strasser-Weippl, 2014, The Lancet. Oncology.

Estimating Carcinogenic Potency from a Rodent Tumorigenicity Experiment

Louise Ryan, Dianne M. Finkelstein, L. Ryan, 1987 .

Isotontic regression for interval censored survival data using an e-m algorithm

Dianne M. Finkelstein, Robert A. Wolfe, R. Wolfe, 1986 .

Bayesian design using adult data to augment pediatric trials

D. Schoenfeld, D. Finkelstein, Hui Zheng, 2009, Clinical trials.

Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests

J. Robins, D. Finkelstein, 2000, Biometrics.

Design considerations for AIDS trials.

D P Byar, V De Gruttola, S B Green, 1990, The New England journal of medicine.

A proportional hazards model for interval-censored failure time data.

D. Finkelstein, D M Finkelstein, 1986, Biometrics.

A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.

A M Zaslavsky, A. Zaslavsky, D. Schoenfeld, 1998, Biometrics.

Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?

Cynthia L. Miller, Barbara L. Smith, M. Specht, 2013, Breast Cancer Research and Treatment.

A model‐informed rank test for right‐censored data with intermediate states

D. Schoenfeld, D. Finkelstein, R. Ramchandani, 2015, Statistics in medicine.

Informatively clustering longitudinal microarrays using binary or survival outcome data

D. Schoenfeld, D. Finkelstein, Jessie J. Hsu, 2018, Communications in statistics. Case studies, data analysis and applications.

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

D. Louis, J. Cairncross, D. Finkelstein, 1998, Journal of the National Cancer Institute.

Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?

M. Mino‐Kenudson, J. Wargo, D. Nehra, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.

D. Louis, G. Harsh, D. Finkelstein, 1996, Journal of neurosurgery.

Physical symptoms in long-term survivors of rare cancer

D. Finkelstein, N. Horick, Kristina L. Boyd, 2018, Journal of Cancer Survivorship.

A proportional hazards model for truncated AIDS data.

D. Schoenfeld, D. Finkelstein, D. Moore, 1993, Biometrics.

Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.

D. Finkelstein, W. Souba, K. Tanabe, 1999, Annals of surgery.

Testing for Dependence Between Failure Time and Visit Compliance with Interval‐Censored Data

Rebecca A Betensky, Dianne M Finkelstein, D. Finkelstein, 2002, Biometrics.

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

S. Spector, D. Finkelstein, S. Bozzette, 1995, The New England journal of medicine.

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.

E. A. Chiocca, D. Louis, T. Deisboeck, 2000, Journal of neurosurgery.

Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.

D. Finkelstein, P. Nguyen, T. Batchelor, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer

D. Finkelstein, W. Westra, P. Busse, 2010, Clinical Cancer Research.

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.

D. Finkelstein, A. Muzikansky, S. Thayer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis

L. Fan, K. Strasser-Weippl, Junjie Li, 2014, Breast Cancer Research and Treatment.

Long-term risk of medical conditions associated with breast cancer treatment

L. Strong, J. Berg, C. Isaacs, 2014, Breast Cancer Research and Treatment.

AIDS clinical trials

D. Schoenfeld, D. Finkelstein, 1995 .

Data Monitoring in the AIDS Clinical Trials Group Study #981: Conflicting Interim Results

D. Finkelstein, 2006 .

A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

H. Waskin, S. Spector, D. Finkelstein, 1995 .

Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group.

D. Finkelstein, D. Cotton, J. Feinberg, 1993, Journal of acquired immune deficiency syndromes.

Gene expression Survival analysis of longitudinal microarrays

D. Schoenfeld, D. Finkelstein, N. Rajicic, 2006 .

A. Buzdar, D. Finkelstein, P. Goss, 2015, European journal of cancer.

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.

W. Gradishar, A. Buzdar, D. Finkelstein, 2013, The Lancet. Oncology.

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy

D. Finkelstein, P. Goss, S. Come, 2014, British Journal of Cancer.

Model‐based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center

Barbara L. Smith, Barbara L. Smith, D. Finkelstein, 2002, Cancer.

ergistic Enhancement of Carboplatin Efficacy with todynamic Therapy in a Three-Dimensional Model for R rometastatic Ovarian Cancer

Adnan O. Abu-Yousif, Rizvi, T. Hasan, 2010 .

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

D. Finkelstein, J. Ruckdeschel, B. Mason, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased Prevalence of EGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms

D. Haber, J. Settleman, D. Bell, 2008, Clinical Cancer Research.

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

D. Finkelstein, A. Sober, F. Haluska, 2000, Archives of Dermatology.

Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project

Swati G. Patel, D. Finkelstein, D. Ahnen, 2016, The American Journal of Gastroenterology.

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.

D. Ettinger, D. Finkelstein, D. Johnson, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of familial aggregation studies with complex ascertainment schemes

D. Finkelstein, R. Betensky, Abigail G Matthews, 2008, Statistics in medicine.

Multivariate logistic regression for familial aggregation in age at disease onset

D. Finkelstein, R. Betensky, Abigail G Matthews, 2007, Lifetime data analysis.

Predictors of skeletal complications in patients with metastatic breast carcinoma

D. Finkelstein, S. Domchek, M. Seiden, 2000, Cancer.

Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.

K. Isselbacher, D. Haber, D. Bell, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of MHC class II DP, DQ and DR alleles in Crohn’s disease

D. Finkelstein, B. Sands, S. Pillai, 1998, Gut.

Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group.

R. Chaisson, D. Finkelstein, W. Powderly, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

T. Rebbeck, S. Gruber, E. Iversen, 2010, Breast Cancer Research and Treatment.

Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.

M. Mino‐Kenudson, D. Finkelstein, C. Bassi, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method.

D. Schoenfeld, D. Finkelstein, 2011, Journal of Clinical Oncology.

Phase II Trial of Acivicin Versus Etoposide‐Cisplatin in Non‐Small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study

D. Finkelstein, P. Bonomi, A. Chang, 1994, American journal of clinical oncology.

Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan.

D. Finkelstein, P. Potter, M. Danks, 2005, Cancer research.

A Pilot Study of the Functional Living Index‐Cancer (FLIC) Scale for the Assessment of Quality of Life for Metastatic Lung Cancer Patients: An Eastern Cooperative Oncology Group Study

D. Finkelstein, J. Wolter, B. Cassileth, 1988, American journal of clinical oncology.

Validity of Models for Predicting BRCA1 and BRCA2 Mutations

Leif E. Peterson, Giovanni Parmigiani, Li Hsu, 2007, Annals of Internal Medicine.

Biologically relevant 3D tumor arrays: treatment response and the importance of stromal partners

Brian W. Pogue, Tayyaba Hasan, Conor L. Evans, 2011, BiOS.

Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation.

D. Finkelstein, Ritesh Ramchandani, D. Schoenfeld, 2022, Statistics in medicine.

Graphing the Win Ratio and its components over time

D. Schoenfeld, D. Finkelstein, 2018, Statistics in medicine.

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector

D. Finkelstein, D. Louis, E. Chiocca, 1998, Gene Therapy.

Analysis of multiple failure time data from an AIDS clinical trial.

D. Schoenfeld, D. Finkelstein, E. Stamenovic, 1997, Statistics in medicine.

Phase II Study of Paclitaxel and Carboplatin for Malignant Melanoma

Jeffrey W. Clark, F. Hodi, D. Finkelstein, 2002, American journal of clinical oncology.

Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).

D. Ettinger, D. Finkelstein, P. Ritch, 2002, Lung cancer.

Abstract PD09-03: Impact of BRCA1/2 Mutation Status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer.

E. Winer, L. Carey, J. Garber, 2012 .

EST 2582 Phase II Trial of Cisplatin in Metastatic or Recurrent Thymoma

D. Ettinger, D. Finkelstein, P. Bonomi, 1993, American journal of clinical oncology.

Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.

D. Ettinger, D. Finkelstein, P. Bonomi, 1992, Journal of the National Cancer Institute.

P1-11-12: Patterns of Care of Newly Diagnosed Patients with Breast Cancer in Mexico.

D. Finkelstein, P. Goss, H. Symecko, 2011 .

Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.

D. Richman, D. Schoenfeld, D. Finkelstein, 1993, AIDS.

Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study.

A. Zietman, D. Finkelstein, W. Shipley, 2000, Urology.

SECOND MALIGNANCIES IN HODGKIN’S DISEASE

D. Finkelstein, A. Aisenberg, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Study of Recombinant Human Interferon-α2a and Zidovudine in Patients with AIDS-Related Kaposi's Sarcoma

D. Finkelstein, R. Steigbigel, M. Fischl, 1996 .

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma

D. Finkelstein, R. Fabian, D. Deschler, 2005, Cancer.

Multimodality management of Merkel cell carcinoma.

M. Gadd, D. Finkelstein, W. Souba, 1999, Archives of surgery.

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

Jeffrey W. Clark, T. Lynch, C. Fuchs, 2000, Cancer.

Irinotecan , in Combination with Cyclophosphamide Carboxylesterase Secreted Human Intestinal and CYP 2 B 1 Genes , Simplex Virus Type 1 Expressing the Prodrug-Activating Brain Tumor Oncolysis with Replication-Conditional Herpes

D. Finkelstein, P. Potter, M. Danks, 2005 .

Delayed Central Nervous System Myelination in the Sudden Infant Death Syndrome

H. Kinney, Betty Ann brody, G. Vawter, 1991, Journal of neuropathology and experimental neurology.

Estimation for an accelerated failure time model with intermediate states as auxiliary information

D. Finkelstein, Ritesh Ramchandani, D. Schoenfeld, 2018, Lifetime Data Analysis.

Strategies for developing biostatistics resources in an academic health center.

J. Ware, F. Harrell, P. Roberson, 2013, Academic medicine : journal of the Association of American Medical Colleges.

Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.

D. Finkelstein, M. Dohn, M. Para, 2000, Journal of acquired immune deficiency syndromes.

Statistical issues arising in AIDS clinical trials

D. Schoenfeld, S. Ellenberg, D. Finkelstein, 1992 .

Comparing treatment strategies using a synthesized clinical trial: an analysis of late versus early use of trimethoprim-sulfamethoxazole for AIDS patients

D. Schoenfeld, D. Finkelstein, 2001 .

Issues in the design of drug trials for AIDS.

S. Green, S. Ellenberg, D. Finkelstein, 1990, Controlled clinical trials.

Methodological issues in AIDS clinical trials

D. Finkelstein, 1992 .

Computer-based interview for screening blood donors for risk of HIV transmission.

C Safran, W V Slack, C. Safran, 1990, JAMA.

Meta-analysis of survey data: application to health services research

Sowmya R. Rao, T. Louis, A. Zaslavsky, 2008, Health Services and Outcomes Research Methodology.

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.

H. Waskin, D. Finkelstein, R. Steigbigel, 1992, The New England journal of medicine.

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

H. Waskin, D. Finkelstein, S. Koletar, 1995, The New England journal of medicine.

Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine

Albert Wu, Judith Feinberg, Tony Cheung, 1996, Annals of Internal Medicine.

Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.

K. Tashima, D. Finkelstein, S. Bozzette, 2002, AIDS research and human retroviruses.

Quantitatively determined survivin expression levels are of prognostic value in human gliomas.

P. Black, D. Finkelstein, A. Chakravarti, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis.

D. Finkelstein, B. Fullerton, J. Loeffler, 2001, International journal of radiation oncology, biology, physics.

Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma.

A. Niemierko, M. Goitein, D. Finkelstein, 1999, International journal of radiation oncology, biology, physics.

Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.

Alfred R. Smith, M. Goitein, D. Finkelstein, 1998, International journal of radiation oncology, biology, physics.

Brainstem tolerance to conformal radiotherapy of skull base tumors.

J. Debus, D. Finkelstein, J. Munzenrider, 1997, International journal of radiation oncology, biology, physics.

Patterns of opportunistic infections in patients with HIV infection.

G Molenberghs, G. Molenberghs, J. Kahn, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

D. Ettinger, D. Finkelstein, D. Trump, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

E. Winer, Minetta C. Liu, L. Carey, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

K. Isselbacher, M. FitzGerald, D. Haber, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.

A. Bowcock, K. Isselbacher, M. FitzGerald, 1997, The New England journal of medicine.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Leif E. Peterson, Giovanni Parmigiani, Christopher I Amos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heterozygous ATM mutations do not contribute to early onset of breast cancer

K. Isselbacher, M. FitzGerald, D. Haber, 1997, Nature Genetics.

A non-parametric maximum likelihood estimator for bivariate interval censored data.

D. Finkelstein, R. Betensky, Dianne M. Finkelstein, 1999, Statistics in medicine.

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Barbara L. Smith, P. Beer-Romero, S. Friend, 1996, The New England journal of medicine.

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

T. Fujii, D. Finkelstein, R. Chung, 2008, JAMA.

Planning cancer control in Latin America and the Caribbean.

Richard Sullivan, Eduardo Cazap, Eduardo Rosenblatt, 2013, The Lancet. Oncology.

High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors.

R. Weissleder, M. Mino‐Kenudson, J. Engelman, 2017, JCO precision oncology.

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

D. Louis, H. Wakimoto, T. Deisboeck, 1999, Nature Medicine.

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

D. Alberts, P. Brown, A. Berchuck, 2017, Clinical Cancer Research.

Are rare cancer survivors at elevated risk of subsequent new cancers?

D. Finkelstein, H. Rana, N. Horick, 2019, BMC Cancer.

Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.

L. Strong, H. Anton-Culver, D. Finkelstein, 2008, Cancer research.

7 q 31 : A Genome-Wide Analysis Common Familial Colorectal Cancer Linked to Chromosome

L. Strong, H. Anton-Culver, D. Finkelstein, 2008 .

Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.

N. Harris, N. Choi, J. Wain, 2000, International journal of radiation oncology, biology, physics.

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

D. Finkelstein, R. Hahn, D. Tormey, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estimation for an accelerated failure time model with intermediate states as auxiliary information

Ritesh Ramchandani, Dianne M Finkelstein, David A Schoenfeld, 2018, Lifetime data analysis.

Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.

D. Finkelstein, A. Muzikansky, J. Pierie, 2003, Journal of the American College of Surgeons.

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease

C. Willett, D. Finkelstein, J. Boivin, 1997, Cancer.

Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas.

D. Finkelstein, D. Fardo, G. Randolph, 2007, Archives of surgery.

Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.

Tayyaba Hasan, Brian W Pogue, Conor L Evans, 2010, Cancer research.

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l

J. McCutchan, D. Finkelstein, J. Currier, 2001, AIDS.

Studying treatments for AIDS: new challenges for clinical trials--a panel discussion at the 1990 annual meeting of the Society for Clinical Trials.

S. Ellenberg, D. Finkelstein, D. Hoth, 1992, Controlled clinical trials.

Evidence for an association between cutaneous melanoma and non‐Hodgkin lymphoma

D. Finkelstein, W. Goggins, H. Tsao, 2001, Cancer.

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Yi Zhang, Jackie Szymonifka, Dennis C. Sgroi, 2013, Journal of the National Cancer Institute.

Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.

D. Finkelstein, R. Murphy, J. Plouffe, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Physical and psychological health in rare cancer survivors

C. Isaacs, D. Finkelstein, S. Domchek, 2017, Journal of Cancer Survivorship.

Survival analysis of longitudinal microarrays

David A. Schoenfeld, Dianne M. Finkelstein, Natasa Rajicic, 2006, Bioinform..

Fine‐needle aspiration cytology of the breast: Invasive vs. in situ carcinoma

D. Finkelstein, D. Finkelstein, R. Tambouret, 2001, Diagnostic cytopathology.

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

L. Devy, R. Jain, Y. Boucher, 2015, Journal of the National Cancer Institute.

Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.

G. Dranoff, D. Finkelstein, G. Reznikoff, 1997, Cancer gene therapy.

A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.

D. Finkelstein, J. Supko, M. Seiden, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.

A. Taghian, K. Hughes, D. Finkelstein, 2009, International journal of radiation oncology, biology, physics.

Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.

E. Wenkel, D. Finkelstein, S. M. de la Monte, 2000, International journal of radiation oncology, biology, physics.

A semiparametric model for regression analysis of interval-censored failure time data.

R. Wolfe, D. Finkelstein, D M Finkelstein, 1985, Biometrics.

Breast cancer in Brazil : present status and future goals

D. Finkelstein, P. Goss, C. Barrios, 2012 .

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.

H. Iwata, D. Finkelstein, C. Barrios, 2019, The Lancet. Oncology.

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy

W. Gradishar, A. Buzdar, K. Strasser-Weippl, 2015, Breast Cancer Research.

A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorder

Tristram H. Smith, Katherine Zanibbi, D. Finkelstein, 2019, Autism : the international journal of research and practice.

Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.

Daniel J Schaid, Colin F Spraggs, Lon R Cardon, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination

D. Finkelstein, M. Siedner, B. Healy, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of the relationship between longitudinal gene expressions and ordered categorical event data

Natasa Rajicic, Dianne M Finkelstein, David A Schoenfeld, 2009, Statistics in medicine.

Design considerations in a sib-pair study of linkage for susceptibility loci in cancer

C. Amos, B. Yeap, D. Finkelstein, 2008, BMC Medical Genetics.

The Cancer Genetics Network: Recruitment Results and Pilot Studies

Prakash Nadkarni, Argyrios Ziogas, Hoda Anton-Culver, 2003, Public Health Genomics.

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

O. Olopade, C. Polanczyk, D. Finkelstein, 2018, Front. Oncol..

Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status

A. Berchuck, M. Greene, S. Buys, 2011, Cancer Prevention Research.

Global rank tests for multiple, possibly censored, outcomes

D. Schoenfeld, D. Finkelstein, Ritesh Ramchandani, 2016, Biometrics.

Combining mortality and longitudinal measures in clinical trials.

D. Schoenfeld, D. Finkelstein, D M Finkelstein, 1999, Statistics in medicine.

Re: Selective Inhibition of Her2-positive Breast Cancer Cells by the Hiv Protease Inhibitor Nelfinavir Notes Erratum: " Comparing Survival of a Sample to That of a Standard Population "

Alona Muzikansky, Dianne M Finkelstein, David A Schoenfeld, 2022 .

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

W. Gradishar, A. Buzdar, K. Strasser-Weippl, 2016, European journal of cancer.

Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study

D. Finkelstein, P. Goss, C. Barrios, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011.

J. St. Louis, D. Finkelstein, P. Goss, 2017, Breast.

A Reliable Method of Demonstrating HER-2/ neu, Estrogen Receptors, and Progesterone Receptors on Routinely Processed Cytologic Material

D. Finkelstein, D. Finkelstein, R. Tambouret, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

Assessing survival benefit when treatment delays disease progression

D. Schoenfeld, D. Finkelstein, 2016, Clinical trials.

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

M. Erlander, D. Sgroi, P. Porter, 2013, Journal of the National Cancer Institute.

Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.

H. Iwata, D. Finkelstein, C. Barrios, 2018 .

Predicting time to prostate cancer recurrence based on joint models for non‐linear longitudinal biomarkers and event time outcomes

D. Pauler, D. Finkelstein, 2002, Statistics in medicine.

Computer interview for screening blood donors for risk of HIV transmission.

C Safran, W V Slack, C. Safran, 1994, M.D. computing : computers in medical practice.

Analysis of familial aggregation in the presence of varying family sizes

Rebecca A. Betensky, Dianne M. Finkelstein, Abigail G. Matthews, 2005 .

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer esearch apeutics , Targets , and Chemical Biology ergistic Enhancement of Carboplatin Efficacy with todynamic Therapy in a Three-Dimensional Model for R rometastatic Ovarian

Rizvi, B. Pogue, T. Hasan, 2010 .

Prevalence of hepatitis B serologic markers in community hospital personnel.

D. Finkelstein, A. McLean, G. Monahan, 1987, American journal of public health.

Prevalence ofHepatitis B Serologic Markers inCommunityHospital Personnel

D. Finkelstein, 1987 .

Design and analysis of a clinical trial using previous trials as historical control

Albert A. Taylor, D. Schoenfeld, D. Finkelstein, 2019, Clinical trials.

TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response.

E. Winer, L. Carey, J. Garber, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysing survival in the presence of an auxiliary variable.

D. Schoenfeld, D. Finkelstein, D M Finkelstein, 1994, Statistics in medicine.

Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009.

E. Winer, Minetta C. Liu, L. Carey, 2014 .

Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease.

D. Sugarbaker, D. Finkelstein, D. Kwiatkowski, 2001, The Journal of thoracic and cardiovascular surgery.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Maristela L Onozato, A. Iafrate, M. Onozato, 2017, Cancer discovery.

A Randomized Trial to Increase Colonoscopy Screening in Members of High-Risk Families in the Colorectal Cancer Family Registry and Cancer Genetics Network

P. Newcomb, R. Sandler, D. Finkelstein, 2014, Cancer Epidemiology, Biomarkers & Prevention.

The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families.

D. Bowen, R. Sandler, D. Finkelstein, 2012, Contemporary clinical trials.

A Proportional Hazards Model for Multivariate Interval‐Censored Failure Time Data

D. Finkelstein, W. Goggins, D M Finkelstein, 2000, Biometrics.

A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE).

H. Iwata, D. Finkelstein, P. Goss, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Access to care issues adversely affect breast cancer patients in Mexico: oncologists’ perspective

J. St. Louis, D. Finkelstein, P. Goss, 2014, BMC Cancer.

Regression analysis of failure time data with informative interval censoring

Jianguo Sun, Dianne M Finkelstein, Liuquan Sun, 2007, Statistics in medicine.

Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework.

Mohammad H Rahbar, Sally C Morton, Shari Messinger, 2015, Academic medicine : journal of the Association of American Medical Colleges.

Breast cancer in Mexico: a growing challenge to health and the health system.

F. Knaul, D. Finkelstein, P. Goss, 2012, The Lancet. Oncology.

The clinical significance of variant-morphology small-cell carcinoma of the lung.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification and Interpretation of Longitudinal Gene Expression Changes in Trauma

D. Schoenfeld, G. O’Keefe, C. Miller‐Graziano, 2010, PloS one.

Clinical Grade “SNaPshot” Genetic Mutation Profiling in Multiple Myeloma

D. Finkelstein, N. Raje, N. Horick, 2014, EBioMedicine.

Clinical grade SNaPshot genetic mutation profiling in multiple myeloma.

A. Iafrate, D. Finkelstein, N. Raje, 2014 .

Dose-volume tolerance of the brainstem after high-dose radiotherapy.

J. Debus, D. Finkelstein, J. Munzenrider, 1999, Frontiers of radiation therapy and oncology.

Imaging enabled platforms for development of therapeutics

Brian W. Pogue, Tayyaba Hasan, Conor L. Evans, 2011, BiOS.

Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma

D. Petereit, D. Finkelstein, D. Deschler, 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.

B. Anderson, D. Finkelstein, L. Laffel, 1997, The Journal of pediatrics.

Clinically relevant changes in family history of cancer over time.

L. Strong, A. Ziogas, H. Anton-Culver, 2011, Journal of the American Medical Association (JAMA).

Analysis of Failure Time Data with Dependent Interval Censoring

Dianne M Finkelstein, David A Schoenfeld, William B Goggins, 2002, Biometrics.

Outcome-Driven Cluster Analysis with Application to Microarray Data

David A. Schoenfeld, Dianne M. Finkelstein, D. Schoenfeld, 2015, PloS one.

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

J. Meyerhardt, M. Tzardi, S. Ogino, 2009, British Journal of Cancer.

Analysis of Failure and Survival Data

Dianne M. Finkelstein, D. Finkelstein, 2002, Technometrics.